Associated Papers
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease.
von Scheidt M et al.
European Heart Journal, 2026
40900105 (PubMed )
Supplement: ehaf602_supplementary_data.pdf
Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets.
Salzbrunn JB et al.
British Journal of Haematology, 2025
40754673 (PubMed )
Supplement: BJH-207-1085-s002.xlsx › CH_cohort
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.
Maffei R et al.
Annals of Hematology, 2025
Genetic diagnostic outcomes from a 10-year research programme in autism in Aotearoa New Zealand.
Musgrave SM et al.
Journal of the Royal Society of New Zealand, 2025
40756852 (PubMed )
Supplement: TNZR_A_2394128_SM9470.xlsx › Sheet1
Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes.
Nead KT et al.
Blood Advances, 2024
38830141 (PubMed )
Supplement: BLOODA_ADV-2024-012929-mmc1.xlsx › STable_2
Landscape of biallelic DNMT3A mutant myeloid neoplasms.
Kawashima N et al.
Journal of Hematology & Oncology, 2024
39334207 (PubMed )
Supplement: 13045_2024_1607_MOESM2_ESM.xlsx › Table_S8
Nonpreferential but Detrimental Accumulation of Macrophages With Clonal Hematopoiesis-Driver Mutations in Cardiovascular Tissues-Brief Report.
Dederichs TS et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2024
38269586 (PubMed )
Supplement: atv-44-690-s001.pdf
ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
West RR et al.
Blood Advances, 2022
34529785 (PubMed )
Supplement: advancesADV2021005065-suppl1.pdf
Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.
Menon MP et al.
The American Journal of Surgical Pathology, 2015
Select a paper to view details